GSK (GSK)

NYSE: GSK · Real-Time Price · USD

38.76

-1.09 (-2.74%)

At close: May 01, 2025, 3:59 PM

38.75

-0.01%

After-hours: May 01, 2025, 04:05 PM EDT

GSK Income Statement

Financials in GBP. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	31.38B	30.33B	29.32B	34.11B	34.1B	33.75B	30.82B	30.19B	27.89B
Cost of Revenue	9.05B	8.56B	9.55B	11.6B	11.7B	11.86B	10.24B	10.34B	9.29B
Gross Profit	22.33B	21.76B	19.77B	22.51B	22.39B	21.89B	20.58B	19.84B	18.6B
Operating Income	4.02B	6.75B	6.43B	6.2B	7.78B	6.96B	5.48B	4.09B	2.6B
Interest Income	60M	40M	76M	28M	44M	98M	81M	65M	72M
Pretax Income	3.48B	6.06B	5.63B	5.44B	6.97B	6.22B	4.8B	3.52B	1.94B
Net Income	2.58B	4.93B	4.92B	4.38B	5.75B	4.64B	3.62B	1.53B	912M
Selling & General & Admin	11.02B	9.38B	8.37B	10.97B	11.46B	11.4B	9.91B	9.67B	9.37B
Research & Development	6.4B	6.22B	5.49B	5.28B	5.1B	4.57B	3.89B	4.48B	3.63B
Other Expenses	891M	-590M	-523M	57M	-1.94B	-1.04B	-292M	-365M	-421M
Operating Expenses	18.31B	15.02B	13.34B	16.31B	14.61B	14.93B	15.1B	15.76B	16B
Interest Expense	640M	775M	879M	784M	892M	912M	798M	734M	736M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	1.38B	1.35B	1.26B
Cost & Expenses	27.36B	23.58B	22.89B	27.91B	26.32B	26.79B	25.34B	26.1B	25.29B
Income Tax Expense	526M	756M	707M	346M	580M	953M	754M	1.36B	877M
Shares Outstanding (Basic)	2.04B	2.03B	2.01B	1.6B	1.99B	1.98B	1.97B	1.95B	1.94B
Shares Outstanding (Diluted)	2.07B	2.06B	2.04B	1.62B	2.02B	2.01B	1.99B	1.98B	1.96B
EPS (Basic)	1.26	2.44	2.44	2.74	2.88	2.34	1.84	0.78	0.48
EPS (Diluted)	1.24	2.40	2.40	2.70	2.86	2.32	1.82	0.78	0.46
EBITDA	6.67B	9.14B	8.63B	7.76B	10.16B	9.38B	9.35B	8.64B	7.06B
EBIT	4.12B	6.79B	6.45B	4.36B	7.81B	7.1B	5.49B	4.26B	2.66B
Depreciation & Amortization	2.55B	2.29B	2.15B	2.12B	2.35B	2.33B	1.86B	1.92B	1.77B